If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,599.00
Bid: 4,546.00
Ask: 4,700.00
Change: 0.00 (0.00%)
Spread: 154.00 (3.388%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,599.00
RKT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

27 Oct 2023 07:00

RNS Number : 4463R
Reckitt Benckiser Group PLC
27 October 2023
 

27 October 2023

 

RECKITT BENCKISER GROUP PLC

 

CHIEF FINANCIAL OFFICER DESIGNATE REMUNERATION

DIRECTOR/PDMR SHAREHOLDING

 

Further to the announcement on 23 August 2023 confirming the appointment of Shannon Eisenhardt as Chief Financial Officer ("CFO") designate with effect from 17 October 2023, and the remuneration outlined within, the Company announces the following detailed remuneration arrangements for Shannon.

 

Shannon's service contract, remuneration and benefits are consistent with the Directors' Remuneration Policy approved by shareholders at the AGM in May 2022.

 

As set out when her appointment was announced, as part of Shannon's remuneration arrangements, she is eligible to receive an initial grant of performance shares and performance options ("Award") under the Company's Long Term Incentive Plan ("LTIP") over ordinary shares of 10 pence each in the share capital of the Company ("Shares"), as well as awards to compensate for remuneration arrangements forfeited on leaving her previous employer, NIKE, Inc. ("Replacement Awards").

 

LTIP Award

 

On 26 October 2023, a grant of 29,453 performance share awards and 58,905 performance share options was made under the Reckitt Benckiser Group plc 2015 Long Term Incentive Plan to Shannon Eisenhardt. As Shannon is participating in the 2023 LTIP at Reckitt, she has not been compensated for any 2023 LTI awards made by her previous employer. The number of Shares and options disclosed is the maximum that will vest if the stretching performance conditions for the three-year performance period ending on 31 December 2025 are satisfied in full. Further details of the performance targets are set out in the Company's 2022 Annual Report. The awards granted are subject to a two-year holding period following the end of the three-year performance period. Options will be exercisable at £58.87 per share. 

 

Replacement Awards

 

· On the same day Shannon was granted two Replacement Awards of performance shares as follows:

 

3,526 performance shares were awarded in relation to the long-term incentive award over NIKE, Inc shares granted to Shannon in August 2021, and vesting based on NIKE, Inc's performance over the three-year period ending 31 May 2024. The number of Shares disclosed is the maximum that may vest if the relevant performance conditions are met in full. Determination of the number of Shares that will vest will be referenced to the information set out in NIKE, Inc's proxy statement describing the extent to which the 2021 Performance Conditions have been satisfied. Vesting of the award will be the later of 1 August 2024, or the date the Committee determines the extent to which the relevant Performance Conditions are satisfied following the end of the relevant Performance Period, but no later than 31 December 2024.

 

5,248 performance shares were awarded in relation to the long-term incentive award over NIKE, Inc shares granted to Shannon in August 2022, and vesting based on the measures and targets for the Reckitt 2022 LTIP awards (as disclosed in the Company's 2021 Annual Report). The number of Shares disclosed is the maximum that may vest if the relevant performance conditions are met in full. The performance period is aligned with the Reckitt 2022 LTIP three-year performance period, ending 31 December 2024.

 

· Furthermore, 5,564 restricted Shares were awarded on the same day in relation to the long-term incentive award over NIKE, Inc shares granted to Shannon in December 2021. Awards are based on continued employment only and will vest in equal tranches in December 2023 and December 2024.

 

These three Replacement Awards will accrue Reckitt dividend equivalents from the time of grant to the time of vesting.

 

No consideration was paid for the grant of these awards. The Replacement Awards will be satisfied by Shares purchased in the market.

 

The following notifications are made in accordance with DTR 3.1.2-A, incorporating article 19(1) of the Market Abuse Regulation.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Shannon Eisenhardt

2

Reason for the notification

a)

Position/status

Chief Financial Officer Designate

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77 - ID code for ordinary shares

b)

Nature of the transaction

Grant of performance share awards for nil consideration under the Reckitt Benckiser Group plc 2015 Long-Term Incentive Plan

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

29,453

 

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Aggregate Total

Nil

29,453

Nil

e)

Date of the transaction

2023-10-26

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77 - ID code for ordinary shares

b)

Nature of the transaction

Grant of performance share options for nil consideration under the Reckitt Benckiser Group plc 2015 Long-Term Incentive Plan

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£58.87

58,905

 

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Aggregate Total

 £58.87

58,905

 £3,467,737.35

e)

Date of the transaction

2023-10-26

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77 - ID code for ordinary shares

b)

Nature of the transaction

Grant of performance share awards for nil consideration in relation to NIKE, Inc long-term incentive award over NIKE, Inc. shares

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

3,526

 

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Aggregate Total

Nil

3,526

Nil

e)

Date of the transaction

2023-10-26

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77 - ID code for ordinary shares

b)

Nature of the transaction

Grant of performance share awards for nil consideration in relation to NIKE, Inc long-term incentive award over NIKE, Inc. shares

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

5,248

 

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Aggregate Total

Nil

5,248

Nil

e)

Date of the transaction

2023-10-26

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77 - ID code for ordinary shares

b)

Nature of the transaction

Grant of restricted share awards for nil consideration in relation to NIKE, Inc long-term incentive award over NIKE, Inc shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

5,564

 

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Aggregate Total

Nil

5,564

Nil

e)

Date of the transaction

2023-10-26

f)

Place of the transaction

Outside a trading venue

 

 

 

For further Information:

 

Catheryn O'Rourke

Company Secretary

 

Tel +44 (0) 1753 217 800

 

 

Richard Joyce

Head of Investor Relations

 

Tel. +44 (0) 7408 812062

 

 

About Reckitt: 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

 

Every day, more than 30 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

 

We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at www.reckitt.com

 

* Reckitt is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXBDGLUDDGXL
Date   Source Headline
13th May 20247:00 amRNSTransaction in Own Shares
10th May 20247:00 amRNSTransaction in Own Shares
9th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:01 amRNSDeath of Independent Non-Executive Director
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20243:57 pmRNSDirector/PDMR Shareholding
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20245:01 pmRNSResult of AGM
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20242:00 pmRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:01 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:01 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNS1st Quarter Results
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 202410:00 amRNSAnnual Financial Report
4th Apr 202410:15 amRNSShare Buyback Programme - Third Tranche
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202410:21 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20243:00 pmRNSDirector Declaration
27th Mar 202411:30 amRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSShare Buyback Programme - Third Tranche
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20244:00 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.